TEK2day FINANCE Open Terminal →

Bio-Rad Laboratories, Inc. (BIO)

NYQ · Healthcare · Medical Devices

$285.94 -2.22%

Closing price as of 2026-06-12 · Source: TEK2day Finance

1-Year Price History +23.0% over period
$345$314$283$252$221 2025-062025-092025-122026-032026-06

Key Metrics

Market Cap
$6.21B
Shares Outstanding
21.7M
P/S (TTM)
2.4x
P/E (TTM)
47.1x
Exchange
NYQ
Currency
USD

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Quarterly Financials

Metric2025-06-302025-09-302025-12-312026-03-31
Revenue651.6M653.0M693.2M592.1M
Gross Profit345.3M343.4M345.2M309.4M
Operating Income77.1M63.9M53.9M34.1M
Net Income317.8M-341.9M720.0M-527.1M
Diluted EPS$11.67$-12.70$26.65$-19.55

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue2.8B2.7B2.6B2.6B
Gross Profit1.6B1.4B1.4B1.3B
Operating Income475.1M337.8M269.0M218.6M
Net Income-3.6B-637.3M-1.8B759.9M
Diluted EPS$-121.79$-21.82$-65.36$27.85
Want live quotes, estimates, SEC filings, and CEO analytics for BIO?
The free TEK2day terminal runs in your browser — type /BIO to get started.
Open BIO in the Terminal →